Medimaps Group
Latest round
- Series C
Last raised
- Nov 2021
Total raised
- $20M
Investors
- 4
About Medimaps Group
Founded in 2006 in Switzerland, Medimaps Group SA focuses on the development of imaging solutions for bone health assessment. The company underwent a strategic pivot towards advanced AI applications, establishing itself as a key player in the digital health sector.Medimaps Group specializes in advanced deep-tech and AI imaging software designed for the comprehensive assessment of bone microarchitecture and the prediction of fracture risk, particularly in primary and secondary osteoporosis. The flagship product, TBS Osteo, integrates Trabecular Bone Score technology to enhance the evaluation of bone health during DXA bone densitometry scans.S. News Best Hospitals Honor Roll for 2024-2025. TBS Osteo, along with its next-generation software that measures soft tissue thickness, caters to clinicians by providing non-invasive, radiation-free solutions that streamline clinical workflows and improve patient care.Medimaps Group generates revenue primarily through the sale of its advanced imaging software solutions, particularly the TBS Osteo platform, which has been integrated into clinical practices across numerous healthcare facilities. The company operates on a business-to-business model, establishing partnerships with hospitals and healthcare providers, who utilize the software as part of their diagnostic and treatment processes. The transactions typically revolve around licensing agreements or subscription-based models that allow healthcare entities to access the software for patient assessments and ongoing monitoring. Furthermore, the TBS Osteo product benefits from dedicated CPT® codes for Medicare beneficiaries, which aids in reimbursement processes under the PFS and OPPS systems, enhancing financial sustainability for healthcare providers using the technology.I. applications for bone health assessment., Europe, Asia, and Latin America, targeting a broader market presence. Through these initiatives, Medimaps Group intends to enhance its offerings and address the growing demand for advanced bone health assessment tools.
Who invested in Medimaps Group
4 investors across 1 round
See all investors in Medimaps Group
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series C
Nov 1, 2021
Amount
$20M
Investors
Questions about Medimaps Group
Who invested in Medimaps Group?
Medimaps Group has 4 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Medimaps Group raised?
Medimaps Group has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Medimaps Group last raise money?
Medimaps Group's most recent round on record is a Series C, in Nov 2021.
What does Medimaps Group do?
Founded in 2006 in Switzerland, Medimaps Group SA focuses on the development of imaging solutions for bone health assessment.
Where is Medimaps Group headquartered?
Medimaps Group is headquartered in Switzerland.
Which VCs invest in companies like Medimaps Group?
Among active investors with capital left to deploy, Index Ventures, European Investment Bank, Highland Europe and Marktlink Capital back software companies at Medimaps Group's stage. Their profiles are linked below.
VCs backing software startups at Series C
Raising like Medimaps Group? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.